Regarding the relationship among tumor growth, the cholesterol pathway, and metformin, Sharma at al. showed increased cholesterol levels and elevated expression of certain cholesterol regulatory genes in malignant breast tumor tissues, such as HMGCR, LDLR, and SREBP1 [12]. Here, SREBF1 is linked to breast cancer.